Analysis of common germline polymorphisms as prognostic factors in patients with lymph node-positive breast cancer

Journal of Cancer Research and Clinical Oncology

Volumn 136, Issue 12, 2010, Pages 1813-1819

  Knechtel, Gudrun ^a   Hofmann, Günter ^a   Gerger, Armin ^a   Renner, Wilfried ^a   Langsenlehner, Tanja ^a   Szkandera, Joanna ^a   Wolf, Gerald ^b   Samonigg, Hellmut ^a   Krippl, Peter ^c   Langsenlehner, Uwe ^d  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b General Hospital of Leoben   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d Internal Outpatient Department   (Austria)

Author keywords

Breast cancer; Lymph node positive; Polymorphism; Prognosis

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALPHA2 INTEGRIN; BETA3 INTEGRIN; CYCLIN D1; CYCLOOXYGENASE 2; FAS ANTIGEN; FAS LIGAND; INTERLEUKIN 10; INTERSTITIAL COLLAGENASE; STROMELYSIN; SULFOTRANSFERASE 1A1; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ADULT; AGED; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GERM LINE; HUMAN; MUTATIONAL ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD95; BREAST NEOPLASMS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GERM-LINE MUTATION; HUMANS; INTERLEUKIN-10; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS;

EID: 78649325636     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-010-0839-2     Document Type: Article

References (42)

1. SP Balasubramanian IA Azmy SE Higham AG Wilson SS Cross A Cox NJ Brown MW Reed 2006 Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review BMC Cancer 6 188 1:STN:280: DC%2BD28rgs1aqug%3D%3D 10.1186/1471-2407-6-188 16842617 (Pubitemid 44295087)
2. BC Barnhart P Legembre E Pietras C Bubici G Franzoso ME Peter 2004 CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells EMBO J 23 3175 3185 1:CAS:528:DC%2BD2cXmt1ajs7w%3D 10.1038/sj.emboj.7600325 15272306 (Pubitemid 39093611)
3. IG Campbell SW Baxter DM Eccles DY Choong 2002 Methylenetetrahydrofolate reductase polymorphism and susceptibility to breast cancer Breast Cancer Res 4 R14 10.1186/bcr457 12473175
4. H Clar U Langsenlehner P Krippl W Renner A Leithner G Gruber G Hofmann B Yazdani-Biuki T Langsenlehner R Windhager 2008 A polymorphism in the G protein beta3-subunit gene is associated with bone metastasis risk in breast cancer patients Breast Cancer Res Treat 111 449 452 1:CAS:528:DC%2BD1cXhtV2js7fO 10.1007/s10549-007-9808-0 17978878
5. KD Crew MD Gammon MB Terry FF Zhang M Agrawal SM Eng SK Sagiv SL Teitelbaum AI Neugut RM Santella 2007 Genetic polymorphisms in the apoptosis-associated genes FAS and FASL and breast cancer risk Carcinogenesis 28 2548 2551 1:CAS:528:DC%2BD2sXhsVWgs77N 10.1093/carcin/bgm211 17962219 (Pubitemid 350238957)
6. DF Fiorentino A Zlotnik TR Mosmann M Howard A O'Garra 1991 IL-10 inhibits cytokine production by activated macrophages J Immunol 147 3815 3822 1:CAS:528:DyaK38XlslSgug%3D%3D 1940369
7. A Gerger U Langsenlehner W Renner W Weitzer T Eder B Yazdani-Biuki G Hofmann H Samonigg P Krippl 2007 A multigenetic approach to predict breast cancer risk Breast Cancer Res Treat 104 159 164 1:CAS:528:DC%2BD2sXnvFKnu7s%3D 10.1007/s10549-006-9408-4 17058024 (Pubitemid 47084229)
8. A Gerger W Renner T Langsenlehner G Hofmann G Knechtel J Szkandera H Samonigg P Krippl U Langsenlehner 2010 Association of interleukin-10 gene variation with breast cancer prognosis Breast Cancer Res Treat 119 701 705 1:CAS:528:DC%2BC3cXlslWkuw%3D%3D 10.1007/s10549-009-0417-y 19437115
9. U Gormus A Ergen I Yaylim-Eraltan H Yilmaz A Turna N Bozkurt T Isbir 2007 Fas-1377 A/G polymorphism in lung cancer In Vivo 21 663 666 1:CAS:528:DC%2BD2sXhtVSiurjK 17708363
10. DL Holliday S Hughes JA Shaw RA Walker JL Jones 2007 Intrinsic gene characteristics determine tumor-modifying capacity of fibroblasts: matrix metalloproteinase-3 5A/5A genotype enhances breast cancer cell invasion Breast Cancer Res 9 67 10.1186/bcr1775 (Pubitemid 350187480)
11. Honig SF (1996) Treatment of metastatic disease: hormonal therapy and chemotherapy. In: Harris JR, Lippman M, Morrow M (eds) Diseases of the breast. Lippincott-Raven Publishers, Philadelphia, pp 669-734
12. WM Howell MJ Rose-Zerilli 2006 Interleukin-10 polymorphisms, cancer susceptibility and prognosis Fam Cancer 5 143 149 1:CAS:528:DC%2BD28XltFWksbY%3D 10.1007/s10689-005-0072-3 16736283 (Pubitemid 43824470)
13. EJ Jacobs HS Feigelson EB Bain KA Brady C Rodriguez VL Stevens AV Patel MJ Thun EE Calle 2006 Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the cancer prevention study II cohort Breast Cancer Res 8 R22 10.1186/bcr1400 16613616 (Pubitemid 44377909)
14. S Kang SM Dong SS Seo JW Kim SY Park 2008 FAS -1377 G/A polymorphism and the risk of lymph node metastasis in cervical cancer Cancer Genet Cytogenet 180 1 5 1:CAS:528:DC%2BD2sXhsVSls73M 10.1016/j.cancergencyto.2007.09.002 18068525 (Pubitemid 350199691)
15. JG Kim YS Chae SK Sohn YY Cho JH Moon JY Park SW Jeon IT Lee GS Choi SH Jun 2008 Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer Clin Cancer Res 14 62 66 1:CAS:528:DC%2BD1cXoslOn 10.1158/1078-0432.CCR-07-1537 18172253 (Pubitemid 351377979)
16. P Krippl U Langsenlehner W Renner B Yazdani-Biuki G Wolf TC Wascher B Paulweber B Bahadori H Samonigg 2003 The L10P polymorphism of the transforming growth factor-beta 1 gene is not associated with breast cancer risk Cancer Lett 201 181 184 1:CAS:528:DC%2BD3sXos1Kmt7k%3D 10.1016/S0304-3835(03)00468-3 14607332 (Pubitemid 37357167)
17. P Krippl U Langsenlehner W Renner B Yazdani-Biuki G Wolf TC Wascher B Paulweber H Samonigg 2004 The 825C>T polymorphism of the G-protein beta-3 subunit gene (GNB3) and breast cancer Cancer Lett 206 59 62 1:CAS:528: DC%2BD2cXhs12mu7c%3D 10.1016/j.canlet.2003.11.030 15019160 (Pubitemid 38281254)
18. U Langsenlehner P Krippl W Renner B Yazdani-Biuki T Eder G Wolf TC Wascher B Paulweber W Weitzer H Samonigg 2004 Genetic variants of the sulfotransferase 1A1 and breast cancer risk Breast Cancer Res Treat 87 19 22 1:CAS:528:DC%2BD2cXnsFOqtr8%3D 10.1023/B:BREA.0000041574.90735.ea 15377847 (Pubitemid 39237779)
19. U Langsenlehner B Yazdani-Biuki T Eder W Renner TC Wascher B Paulweber W Weitzer H Samonigg P Krippl 2006 The cyclooxygenase-2 (PTGS2) 8473T>C polymorphism is associated with breast cancer risk Clin Cancer Res 12 1392 1394 1:CAS:528:DC%2BD28XhsFalurk%3D 10.1158/1078-0432.CCR-05-2055 16489098 (Pubitemid 43342533)
20. L Le Marchand CA Haiman D van den Berg LR Wilkens LN Kolonel BE Henderson 2004 T29C polymorphism in the transforming growth factor beta1 gene and postmenopausal breast cancer risk: the Multiethnic Cohort Study Cancer Epidemiol Biomarkers Prev 13 412 415 1:CAS:528:DC%2BD2cXhvVygt7o%3D 15006917
21. JK Lee TJ Sayers TC Back JM Wigginton RH Wiltrout 2003 Lack of FasL-mediated killing leads to in vivo tumor promotion in mouse Lewis lung cancer Apoptosis 8 151 160 1:CAS:528:DC%2BD3sXit12ksb0%3D 10.1023/A: 1022918625509 12766475 (Pubitemid 36547102)
22. H Lei J Zaloudik L Vorechovsky 2002 Lack of association of the -1171 (5A) allele of the MMP3 promoter with breast cancer Clin Chem 48 798 799 1:CAS:528:DC%2BD38XjtlWntbo%3D 11978619
23. T Lifsted T Le Voyer M Williams W Muller A Klein-Szanto KH Buetow KW Hunter 1998 Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression Int J Cancer 77 640 644 1:STN:280:DyaK1czktleltg%3D%3D 10.1002/(SICI)1097-0215(19980812)77:4<640:: AID-IJC26>3.0.CO;2-8 9679770 (Pubitemid 28340915)
24. M Linnebank A Semmler S Moskau Y Smulders H Blom M Simon 2008 The methylenetetrahydrofolate reductase (MTHFR) variant c.677C>T (A222 V) influences overall survival of patients with glioblastoma multiforme Neuro Oncol 10 548 552 1:CAS:528:DC%2BD1cXhtVymsrbN 10.1215/15228517-2008-020 18497326
25. LM McShane DG Altman W Sauerbrei SE Taube M Gion GM Clark 2006 REporting recommendations for tumor MARKer prognostic studies (REMARK) Breast Cancer Res Treat 100 229 235 10.1007/s10549-006-9242-8 16932852 (Pubitemid 44631925)
26. S Mocellin F Marincola CR Rossi D Nitti M Lise 2004 The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle Cytokine Growth Factor Rev 15 61 76 1:CAS:528:DC%2BD2cXmvFKktQ%3D%3D 10.1016/j.cytogfr.2003.11.001 14746814 (Pubitemid 38121291)
27. M Müschen U Warskulat MW Beckmann 2000 Defining CD95 as a tumor suppressor gene J Mol Med 78 312 325 10.1007/s001090000112 11001528
28. S Nagata P Golstein 1995 The Fas death factor Science 267 1449 1456 1:CAS:528:DyaK2MXktlClt7w%3D 10.1126/science.7533326 7533326
29. DM Parkin F Bray J Ferlay P Pisani 2005 Global cancer statistics 2002 CA Cancer J Clin 55 74 108 10.3322/canjclin.55.2.74 15761078
30. LX Qui J Shi H Yuan X Jiang K Xue HF Pan J Li MH Zheng 2009 FAS-1377 G/A polymorphism is associated with cancer susceptibility: evidence from 10,564 cases and 12,075 controls Hum Gen 125 431 435 10.1007/s00439-009-0639-4
31. H Shinohara H Yagita Y Ikawa N Oyaizu 2000 Fas drives cell cycle progression in glioma cells via extracellular signal-regulated kinase activation Cancer Res 60 1766 1772 1:CAS:528:DC%2BD3cXit1aqurw%3D 10749152
32. K Sibley S Rollinson JM Allan AG Smith GR Law PL Roddam CF Skibola MT Smith GJ Morgan 2003 Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia Cancer Res 63 4327 4330 1:CAS:528:DC%2BD3sXmtFekurs%3D 12907599
33. T Sun X Miao X Zhang W Tan P Xiong D Lin 2004 Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma J Natl Cancer Inst 96 1030 1036 1:CAS:528:DC%2BD2cXlsFyis74%3D 10.1093/jnci/djh187 15240787
34. H Takayama T Takakuwa Y Tsujimoto N Nonomura A Okuyama K Aozasa 2002 Analysis of Fas gene mutations on laser capture microdissected specimens from renal cell carcinoma Jpn J Cancer Res 93 1201 1206 1:CAS:528: DC%2BD3sXnvVCrsg%3D%3D 12460460
35. M Ter-Minassian R Zhai K Asomaning L Su W Zhou G Liu RS Heist TJ Lynch JC Wain X Lin I De Vivo DC Christiani 2008 Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer Carcinogenesis 29 2147 2152 1:CAS:528:DC%2BD1cXhtlalsLbK 10.1093/carcin/bgn205 18757527
36. DM Turner DM Williams D Sankaran M Lazarus PJ Sinnott IV Hutchinson 1997 An investigation of polymorphism in the interleukin-10 gene promoter Eur J Immunogenet 24 1 8 1:CAS:528:DyaK2sXhsFCjsL0%3D 9043871
37. DE Wesche-Soldato RZ Swan CS Chung A Ayala 2007 The apoptotic pathway as a therapeutic target in sepsis Curr Drug Targets 8 493 500 1:CAS:528: DC%2BD2sXjsF2qs7g%3D 10.2174/138945007780362764 17430119 (Pubitemid 46672616)
38. L Yang LM DeBusk K Fukuda B Fingleton B Green-Jarvis Y Shyr LM Matrisian DP Carbone PC Lin 2004 Expansion of myeloid immune suppressor Gr + CD11b + cells in tumor-bearing host directly promotes tumor angiogenesis Cancer Cell 6 409 421 1:CAS:528:DC%2BD2cXpsF2rtLo%3D 10.1016/j.ccr.2004.08.031 15488763 (Pubitemid 39361441)
39. I Yaylim-Eraltan A Ergen U Görmüs S Arikan S Küçücük O Sahin N Yigit Y Yildiz T Isbir 2009 Breast cancer and cyclin D1 gene polymorphism in Turkish women In Vivo 23 767 772 1:CAS:528:DC%2BD1MXht12hurbE 19779113
40. Z Zhang LE Wang EM Sturgis AK El-Naggar WK Hong CI Amos MR Spitz Q Wei 2006 Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck Clin Cancer Res 12 5596 5602 1:CAS:528:DC%2BD28XpvFSht74%3D 10.1158/1078-0432.CCR-05- 1739 17000697 (Pubitemid 44497278)
41. B Zhang T Sun L Xue X Han B Zhang N Lu Y Shi W Tan Y Zhou D Zhao X Zhang Y Guo D Lin 2007 Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer Carcinogenesis 28 1067 1073 1:CAS:528:DC%2BD2sXlvFGlsbo%3D 10.1093/carcin/bgl250 17183065 (Pubitemid 47072192)
42. Y Zhang Q Liu M Zhang Y Yu X Liu X Cao 2009 Fas signal promotes lung cancer growth by recruiting myeloid-derived suppressor cells via cancer cell-derived PGE2 J Immunol 182 3801 3808 1:CAS:528:DC%2BD1MXis12hsLY%3D 10.4049/jimmunol.0801548 19265159